Diabetes Care Devices - United Kingdom

Revenue in the Diabetes Care Devices market market in the United Kingdom is projected to reach US$916.60m in 2024.
Revenue is expected to exhibit an annual growth rate (CAGR 2024-2029) of 13.92%, leading to a market volume of US$1.76bn by 2029.
In a global context, the majority of revenue will be generated the United States, which is anticipated to reach US$11.71bn in 2024.
In the United Kingdom, the Diabetes Care Devices market is witnessing a shift towards innovative digital solutions that enhance patient monitoring and self-management.

Definition:
The Diabetes Care Devices market, a medical technology market, includes medical devices used in the management and treatment of diabetes. These devices range from blood glucose meters and continuous glucose monitoring systems to insulin pumps, insulin pens, and other related accessories. It is important to note that the market does not include pharmaceutical products used in the treatment of diabetes, such as insulin and oral hypoglycemic agents.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Medtronic, Abbott Laboratories, and Roche Diagnostics. Further information on the key players can be found in the Market Shares boxes.

Blood glucose monitoring devices
Insulin delivery devices

Diabetes drugs
Diabetes supplements

The Diabetes Care Devices Market in the United Kingdom is witnessing substantial growth, fueled by factors like technological advancements, increasing prevalence of diabetes, and heightened awareness of diabetes management among patients and healthcare providers.

Customer preferences: Consumers in the United Kingdom are increasingly gravitating towards integrated diabetes care solutions, reflecting a shift towards personalized health management. This trend is influenced by a growing preference for devices that offer real-time data tracking and mobile app connectivity, enabling users to monitor their glucose levels effortlessly. Additionally, younger demographics are embracing smart technology, seeking devices that seamlessly blend into their lifestyles. The rising emphasis on holistic health approaches is also encouraging patients to prioritize education and self-management tools in their diabetes care.

Trends in the market: In the United Kingdom, the Diabetes Care Devices Market is experiencing a surge in demand for continuous glucose monitoring (CGM) systems and insulin delivery devices that integrate with mobile technology. This trend is driven by a desire for real-time data analytics and personalized health insights, allowing users to optimize their diabetes management. The growing emphasis on preventive healthcare and patient empowerment is prompting stakeholders to invest in educational platforms and user-friendly interfaces. Consequently, manufacturers and healthcare providers must adapt their strategies to leverage these advancements, ensuring they meet the evolving needs of tech-savvy consumers.

Local special circumstances: In the United Kingdom, the Diabetes Care Devices Market is shaped by a robust healthcare system and a strong regulatory framework that prioritizes patient safety and innovation. The National Health Service (NHS) plays a critical role in subsidizing advanced diabetes technologies, making them accessible to a broader population. Cultural factors, such as a high level of health awareness and engagement in self-management, further drive demand for CGM systems and insulin delivery devices. Additionally, the UK's emphasis on data privacy and security influences the development of user-friendly yet compliant technologies, ensuring that consumer confidence remains high.

Underlying macroeconomic factors: The Diabetes Care Devices Market in the United Kingdom is significantly influenced by macroeconomic factors such as national economic stability, healthcare funding, and global supply chain dynamics. A strong UK economy, bolstered by government initiatives to invest in healthcare innovation, enhances the accessibility and affordability of diabetes care technologies. Moreover, fluctuations in currency exchange rates can impact import costs for advanced medical devices. The rising prevalence of diabetes, coupled with increased health expenditures, drives demand for cutting-edge diabetes management solutions. Regulatory support and a focus on research and development further propel market growth, ensuring that patients benefit from the latest advancements in diabetes care.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.